KYMR

KYMERA THERAPEUTICS, INC.

KYMR · CIK 1815442 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$39M
20202025
Net Income−$311M
20202025
Operating CF−$233M
20202025
Free Cash Flow−$234M
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.0B$0.0B$0.1B$0.0B$0.1B$0.0B
Cost of Revenue$0.0B$0.0B————
Gross Profit——————
R&D Expense$0.3B$0.2B$0.2B$0.2B$0.1B$0.1B
SG&A Expense——————
Operating Income$-0.3B$-0.3B$-0.2B$-0.2B$-0.1B$-0.0B
Net Income$-0.3B$-0.2B$-0.1B$-0.2B$-0.1B$-0.0B
EPS (Basic)$-3.69$-2.98$-2.52$-2.87——
EPS (Diluted)$-3.69$-2.98$-2.52$-2.87——

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$1.7B$1.0B$0.6B$0.6B$0.6B$0.5B
Current Assets$0.9B$0.5B$0.4B$0.4B$0.5B$0.3B
Cash & Equivalents$0.4B$0.1B$0.1B$0.1B$0.0B$0.0B
Total Liabilities$0.2B$0.1B$0.2B$0.1B$0.1B$0.2B
Current Liabilities$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity$1.6B$0.8B$0.4B$0.5B$0.5B$0.3B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.2B$-0.2B$-0.1B$-0.2B$-0.1B$0.1B
Investing Cash Flow$-0.5B$-0.4B$0.1B$0.0B$-0.1B$-0.4B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$1.0B$0.6B$0.0B$0.2B$0.3B$0.3B
← Companies